The purpose of the study was to evaluate the short term 
general practice in Inner London, who accepted the offer of carrier testing, completed questionnaires before testing, upon receipt of results, and three months later. Full data were obtained from 427 with negative test results and 14 carriers.
Receipt of results had no effect upon perceptions of health or perceived risk of having an abnormal baby. Those receiving a positive test result were significantly more anxious upon receipt of this result. By three months, this anxiety had dissipated. While knowledge of the test improved from before to after testing, by three months there was some decay. Although the residual risk among those with a negative result of being a carrier was given as 1:135, at least 17% of those receiving a negative result incorrectly believed that they were at no risk of having a child with cystic fibrosis. Five of the 14 receiving a positive result erroneously believed that their results meant that they probably, but not definitely, carried the gene for cystic fibrosis. In the longer term the greatest problem of population screening would appear to be one of false reassurance rather than anxiety. Longer term studies are needed to determine how well carrier status information is retained, and how carriers and carrier couples plan and respond to pregnancy and how much understanding they retain of their test results. The most frequently chosen adjectives to describe reactions to a negative test result were pleased, happy, and relieved. The next most frequently chosen adjective was healthy. Those receiving positive results were more likely to respond initially with feeling of surprise and upset.
Upon receipt of test results, those receiving a positive result were significantly more anxious than those receiving a negative result; three months later this difference was no longer apparent (repeated measures MANOVA: F(2,958) = 3-8, p < 0 024) (figure).
Receipt of negative or positive results had no evident effects upon perceptions of 14) Negative-population based Finally, the tendency for results to be misremembered in a direction that underplays a person's risk is similar to a more general and well described tendency for people to be optimistic in appraising their health as well as other personal attributes.'3 This has been seen as a self-serving bias, defending the person against the possibilities of misfortune.
Aside from these psychological mechanisms, a cause of and solution to these misunderstandings may lie in the counselling people received before and after testing. The meaning of all test results was emphasised in the written information and the information provided verbally before testing, and in the letters conveying test results. Given the primary care setting of the study, one way of addressing the decrease in understanding is for health professionals to use consultations as an opportunity to discuss and check understanding of any test results.
We did not confirm an earlier finding of reduced optimism in future health among carriers. This could be because of many differences between the two studies: time since carrier detection, nature of conditions being screened for, method of screening. There was some evidence, however, that for some people undergoing screening called into question their general health. So, for example, 10% of those receiving a negative result on the population based screening programme described feeling healthy upon receipt of their results. One of the carriers, herself a health professional, considered attributing previous ailments to carrying the gene: "I wondered if the fact that I have a number of allergies may be a tenuous link in a way ... And when I have a cold it tends to go to my chest . ." (0505).
Many of those found to be carriers were uncertain about how they would respond when actively contemplating pregnancy. Although not assessed formally, it became apparent during interviews with six of the carriers that their understanding of CF was extremely limited. The amount of information provided in the study about CF was brief and similar to that provided in other reported studies.*0Oll It is evident, however, that probably largely as a result of this, people were poorly informed about the nature and severity of the disease. Most carriers overestimated the severity of cystic fibrosis. The information provided in the study information booklet given to all those tested stated that even with intensive treatment people with the disease usually died in early adulthood. While this is arguably a rather pessimistic picture of the outcome for children born now with CF,14 the understanding of most carriers was even more gloomy.
In response to a question asking how much she knew about CF, one carrier responded:
"It affects the lungs, and it's quite distressing for the children in that they can't breathe properly and they don't survive into adulthood. I'm not actually very clear if it affects the brain or not ... I wondered if there was a lack of oxygen or something and it was related to that." (0014).
Another, in response to a question about the life expectancy of someone with CF replied: "I'd seen someone (with CF) who is 26; that was very unusual. I would have thought it was just childhood really, about 5 or 6 years old or a bit older but not reaching into adulthood." (0650).
Another in response to the same question:
"I believe it is no longer than 12.... But mainly it's 2 to 5 years." (1103).
Given that perceived burden is an important predictor of the use of prenatal diagnosis and termination of pregnancy,'5 it is important that those undergoing testing are given more information about the condition for which they are found to be carriers.
The main reason for offering carrier detection to the general population and not just to those who are pregnant is that if carrier couples learn that they carry the mutated gene before pregnancy, then they have more reproductive options, including the option not to have children. It has also been suggested that it allows more time to decide whether to undergo prenatal testing outside of the emotional intensity that characterises pregnancy. While we now know the initial responses of non-carriers to testing, longer term studies are needed to determine how well carrier status information is retained, and how carrier couples, in particular, plan and respond to pregnancy, and whether there are residual anxieties about carrier status.
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